1. Home
  2. SRRK vs DEI Comparison

SRRK vs DEI Comparison

Compare SRRK & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • DEI
  • Stock Information
  • Founded
  • SRRK 2012
  • DEI 1971
  • Country
  • SRRK United States
  • DEI United States
  • Employees
  • SRRK N/A
  • DEI N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • DEI Real Estate Investment Trusts
  • Sector
  • SRRK Health Care
  • DEI Real Estate
  • Exchange
  • SRRK Nasdaq
  • DEI Nasdaq
  • Market Cap
  • SRRK 2.9B
  • DEI 2.8B
  • IPO Year
  • SRRK 2018
  • DEI 2006
  • Fundamental
  • Price
  • SRRK $30.75
  • DEI $13.99
  • Analyst Decision
  • SRRK Strong Buy
  • DEI Buy
  • Analyst Count
  • SRRK 6
  • DEI 9
  • Target Price
  • SRRK $42.17
  • DEI $18.50
  • AVG Volume (30 Days)
  • SRRK 1.6M
  • DEI 2.6M
  • Earning Date
  • SRRK 05-06-2025
  • DEI 05-06-2025
  • Dividend Yield
  • SRRK N/A
  • DEI 5.42%
  • EPS Growth
  • SRRK N/A
  • DEI N/A
  • EPS
  • SRRK N/A
  • DEI 0.13
  • Revenue
  • SRRK N/A
  • DEI $989,071,000.00
  • Revenue This Year
  • SRRK N/A
  • DEI $0.56
  • Revenue Next Year
  • SRRK $601.05
  • DEI N/A
  • P/E Ratio
  • SRRK N/A
  • DEI $105.77
  • Revenue Growth
  • SRRK N/A
  • DEI 0.46
  • 52 Week Low
  • SRRK $6.76
  • DEI $12.39
  • 52 Week High
  • SRRK $46.98
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 49.04
  • DEI 40.38
  • Support Level
  • SRRK $28.79
  • DEI $13.65
  • Resistance Level
  • SRRK $31.09
  • DEI $14.50
  • Average True Range (ATR)
  • SRRK 2.50
  • DEI 0.86
  • MACD
  • SRRK 0.44
  • DEI -0.05
  • Stochastic Oscillator
  • SRRK 78.82
  • DEI 40.71

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.

Share on Social Networks: